CRIPTO’s effects on breast cancer cells are likely mediated by its joint modulation of the TGF-β pathway and growth factor-like signaling (i.e., activation of SRC/MAPK/PI3K pathways), and there may also be important roles for other pathways regulated by CRIPTO including WNT and NOTCH [33, 34]. The gene discussed is CRIPTO; the disease is breast cancer.